Pembrolizumab combined with gemcitabine-based chemoradiation is feasible and effective in patients with muscle-invasive bladder cancer (MIBC).

An innovative treatment for bladder cancer successfully prevented the recurrence of tumors and improved survival rates following surgery.

Immunotherapy uses the power of your immune system to fight your cancer. One type of immunotherapy is called an immune checkpoint inhibitor. Your immune system has built-in checkpoints that help it ...

Dr. David Greenberg outlines bladder cancer staging, BCG, immunotherapy, surgery, quality of life impacts and long-term ...

If you or a loved one has been diagnosed with BCG-unresponsive non-muscle invasive bladder cancer and are exploring your ...

Researchers at the Icahn School of Medicine at Mount Sinai and the Mount Sinai Tisch Cancer Center have discovered a biological pathway that helps explain why some bladder cancers do not respond well ...

The U.S. Food and Drug Administration has granted approval for a new immunotherapy treatment for advanced stages of the most common type of bladder cancer — urothelial carcinoma — the agency announced ...

Recent advances in immunotherapy and combination therapies are revolutionizing the treatment landscape for both metastatic and muscle-invasive urothelial cancer. In advanced urothelial cancer, in ...

ImmunityBio will present new findings on its Anktiva immunotherapy combined with BCG for non-muscle-invasive bladder cancer ...

Add Yahoo as a preferred source to see more of our stories on Google. Patients with advanced bladder cancer have significantly less risk of the disease progressing or returning when treated with an ...

A drug that helps the immune system find cancer cells also helps patients avoid having their bladders surgically removed (cystectomy), a new study shows. The findings apply to serious cases after ...